Drug Shortage Report for VENLAFAXINE XR
| Report ID | 183708 |
| Drug Identification Number | 02516535 |
| Brand name | VENLAFAXINE XR |
| Common or Proper name | Venlafaxine Hydrochloride |
| Company Name | JAMP PHARMA CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | VENLAFAXINE |
| Strength(s) | 37.5MG |
| Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
| Route of administration | ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 100 |
| ATC code | N06AX |
| ATC description | ANTIDEPRESSANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-02-06 |
| Estimated end date | 2025-02-15 |
| Actual end date | 2025-03-17 |
| Shortage status | Resolved |
| Updated date | 2025-03-18 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v29 | 2025-03-18 | French | Compare |
| v28 | 2025-03-18 | English | Compare |
| v27 | 2025-01-04 | French | Compare |
| v26 | 2025-01-04 | English | Compare |
| v25 | 2024-12-03 | French | Compare |
| v24 | 2024-12-03 | English | Compare |
| v23 | 2024-11-01 | French | Compare |
| v22 | 2024-11-01 | English | Compare |
| v21 | 2024-07-29 | French | Compare |
| v20 | 2024-07-29 | English | Compare |
| v19 | 2024-03-30 | French | Compare |
| v18 | 2024-03-30 | English | Compare |
| v17 | 2024-02-06 | French | Compare |
| v16 | 2024-02-06 | English | Compare |
| v15 | 2023-12-30 | French | Compare |
| v14 | 2023-12-30 | English | Compare |
| v13 | 2023-11-15 | French | Compare |
| v12 | 2023-11-15 | English | Compare |
| v11 | 2023-09-26 | French | Compare |
| v10 | 2023-09-26 | English | Compare |